Navigation Links
The PLSG Invests $115,000 in Innovention Technologies, LLC
Date:10/24/2007

PITTSBURGH, Oct. 24 /PRNewswire/ -- The Pittsburgh Life Sciences Greenhouse (PLSG), the private/public partnership putting the region's life sciences industry on a fast track for growth, announced that the PLSG has invested $115,000 in Innovention Technologies, LLC, a developmental-stage medical device company, whose goal is to develop and commercialize a highly-maneuverable surgical probe that will alleviate the existing limitations of endoscopic devices used in minimally invasive surgery (MIS).

Innovention Technologies is a spin-out from Carnegie Mellon University and it is led by an interdisciplinary team of experts in robotics, robotic surgery and minimally-invasive cardiac surgery (MICS).

Innovention Technologies is developing advanced robotic technologies for use in a wide range of applications, including: medical, industrial, military and law enforcement. The company's highly articulated robotic probes have unlimited degrees of freedom, are teleoperated, and are able to steer a self-supported, non-linear path. Innoventions' first product is a highly-articulated robotic probe (HARP) with feeder (the "HARP Product"). The HARP Product is highly maneuverable and once entered through a natural orifice or small incision, is designed to steer around organs to reach anatomical targets not normally accessible by conventional endoscopic tools. The HARP mechanical features include its ability to alternate between being rigid and flexible, and "remember" its previous configurations. This allows the HARP to reach very small cavities within the body and remain in a desired shape and orientation while the doctor performs surgery without having to hold the device anymore.

"The PLSG is excited to support Innoventions' continued commercialization efforts. Innoventions' core technology promises to combine advanced, yet simple methodologies in robotic surgery to more effectively deliver intended surgical benefits for increased patient care," said John W. Manzetti, PLSG's President and CEO. Mr. Manzetti continued, "The experienced management team has combined MIS and an emerging robotics technology to strategically and competitively position Innoventions in a large medical device market."

About the Pittsburgh Life Sciences Greenhouse (PLSG)

The PLSG invests in and supports the growth of biosciences companies in southwestern Pennsylvania. The PLSG has investment and business growth programs to increase the linkage between research, technology and commercialization; nurture and develop entrepreneurial biosciences enterprises; grow the region's talent pool in the life sciences; and help biosciences firms locate, expand or start-up in the Greater Pittsburgh region. http://www.plsg.com

About Innovention Technologies, LLC

Innovention Technologies LLC is developing advanced robotic technologies for use in a wide range of applications, including: medical, industrial, military and law enforcement. The Company's highly articulated robotic probes have unlimited degrees of freedom, are teleoperated, and are able to steer a self-supported, non-linear path. Within the medical field, the Company plans to serve a number of different specialist areas, including: minimally-invasive cardiac surgery, electrophysiology, laparoscopy, colonoscopy and arthroscopy. http://www.innoventllc.com


'/>"/>
SOURCE Pittsburgh Life Sciences Greenhouse
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Milwaukee angel network invests in St. Louis company
2. Froedtert invests $1.5M in local medical imaging startup
3. GE Healthcare invests $37.5 million in Chinese bio-sciences manufacturing facility
4. Wisconsin Insurance Company Invests in DotCom Company
5. Madison business receives $115,000 of new state biofuels funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today announced ... to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B ... to cross the cell membrane and bind intracellular STAT3 and inhibit its function. ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive ... a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... ... 10, 2017 , ... Dr. Bob Harman, founder and CEO of VetStem ... The event entitled “Stem Cells and Their Regenerative Powers,” was held ... Harman, DVM, MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief ...
(Date:10/10/2017)... SomaGenics announced the receipt of a Phase ... (Single Cell), expected to be the first commercially available ... from single cells using NGS methods. The NIH,s recent ... development of approaches to analyze the heterogeneity of cell ... for measuring levels of mRNAs in individual cells have ...
Breaking Biology Technology:
(Date:8/15/2017)... --  ivWatch LLC , a medical device company focused on improving ... of its ISO 13485 Certification, the global standard for medical device ... (ISO®). ... Monitoring device for the early detection of IV infiltrations. ... "This is an important milestone for ivWatch, as it ...
(Date:6/14/2017)... (NYSE: IBM ) is introducing several innovative partner startups ... collaboration between startups and global businesses, taking place in ... nine startups will showcase the solutions they have built with ... France is one of the ... percent increase in the number of startups created between 2012 ...
(Date:5/6/2017)... SINGAPORE , May 5, 2017 ... has just announced a new breakthrough in biometric ... that exploits quantum mechanical properties to perform ... new smart semiconductor material created by Ram Group ... across finance, entertainment, transportation, supply chains and security. ...
Breaking Biology News(10 mins):